Clinical Trial Update: Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD). [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating prevention of recurrent Clostridioides difficile infection in patients with inflammatory bowel disease. The study was terminated and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection
• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Snippet

Sponsor: David Binion, MD | Conditions: Inflammatory Bowel Diseases, Ulcerative Colitis | Phase 4 | Status: TERMINATED | Results posted: 2025-06-05